Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 14/12/2017
SIETES contiene 92152 citas

 
 
 1 a 20 de 828 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Crowther CA, Middleton PF, Voysey M, Askie L, Duley L, Pryde PG, Marret S, Doyle LW, for the AMICABLE Group. Assessing the neuroprotective benefits for babies of antenatal magnesium sulphate: An individual participant data meta-analysis. PLOS Medicine 2017:4 de octubre. [Ref.ID 102113]
2. Cita con resumen
Ebell MH. WHO downgrades status of oseltamivir. BMJ 2017;358:j3266. [Ref.ID 101981]
3. Cita con resumen
Ralph AP, Noonan S, Boardman C, Halkon C, Currie BJ. Prescribing for people with acute rheumatic fever. Australian Prescriber 2017;40:70-5. [Ref.ID 101520]
6. Cita con resumen
Gunn JKL, Rosales CB, Nuñez A, Gibson SJ, Christ C, Ehri JE. Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis. BMJ Open 2016;6:e009986. [Ref.ID 100112]
7. Cita con resumen
Tuuli MG, Liu J, Stout MJ, Martin S, Cahill AG, Odibo AO, Colditz GA, Macones GA. A randomized trial comparing skin antiseptic agents at cesarean delivery. N Engl J Med 2016;374:18 de febrero. [Ref.ID 99994]
8. Cita con resumen
Boussageon R, Gueyffier F, Cornu C. Metformin as firstline treatment for type 2 diabetes: are we sure?. BMJ 2016;352:h6748. [Ref.ID 99967]
9.Tiene citas relacionadas Cita con resumen
Gágyor I, Bleidorn J, Kochen MM, Schmiemann G, Wegscheider K, Hummers-Pradier E. Ibuprofen versus fosfomycin for uncomplicated urinary tract infection in women: randomised controlled trial. BMJ 2015;351:h6544. [Ref.ID 99824]
10. Cita con resumen
Hakkara TW, Steel SR, Bastaworous A, Dellinger EP, Farrokhi E, Farjah F, Florence M, Helton S, Horton M, Pietro M, Varghese TK, Flum DR. Nonsteroidal anti-inflammatory drugs and the risk for anastomotic failure. A report from Washington state’s Surgical Care and Outcomes Assessment Program (SCOAP) . JAMA Surgery 2015;150:223-8. [Ref.ID 99822]
11. Cita con resumen
Jorgensen ME, Hlatky MA, Kober L, Sanders RD, Torp-Pedersen C, Gislason GH, Jensen PF, Andersson C. ß-blocker-associated risks in patients with uncomplicated hypertension undergoing noncardiac surgery. JAMA Intern Med 2015;175:1923-31. [Ref.ID 99749]
13. Cita con resumen
Mansi I, Frei CR, Wang CP, Mortensen EM. Statins and new-onset diabetes mellitus and diabetic complications: a retrospective cohort study of US healthy adults. J Gen Intern Med 2015;30:1599-610. [Ref.ID 99679]
14. Cita con resumen
Kalra L, Irshad S, Hodsoll J, Simpson M, Gulliford M, Smithard D, Patel A, Rebollo-Mesa I, on behalf of the STROKE-INF Investigators. Prophylactic antibiotics after acute stroke for reducing pneumonia in patients with dysphagia (STROKE-INF): a prospective, cluster-randomised, open-label, masked endpoint, controlled clinical trial. Lancet 2015;386:1835-44. [Ref.ID 99670]
15. Cita con resumen
Naci H, Lehman R, Wouters OJ, Goldacre B, Yudkin JS. Rethinking the appraisal and approval of drugs for type 2 diabetes. BMJ 2015;351:h5260. [Ref.ID 99594]
16. Cita con resumen
Dalsgaard S, Ostergaard D, Leckman JF, Mortensen PB, Pedersen MG. Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a nationwide cohort study. Lancet 2015;385:2190-6. [Ref.ID 99164]
17.Tiene citas relacionadas Cita con resumen
Lip GY, Skjoth F, Rasmussen LH, Larsen TB. Oral anticoagulation, aspirin, or no therapy in patients with nonvalvular AF with 0 or 1 stroke risk factor based on the CHA2DS2-VASc score. J Am Coll Cardiol 2015;65:1385-94. [Ref.ID 99047]
18.Tiene citas relacionadas Cita con resumen
Friberg L, Skeppholm M, Terént A. Benefit of anticoagulation unlikely in patients with atrial fibrillation and a CHA2DS2-VASc score of 1. J Am Coll Cardiol 2015;65:225-32. [Ref.ID 99044]
19.Tiene citas relacionadas Cita con resumen
Fleischmann KE. Should we anticoagulate patients with CHA2DS2-VASc scores of 1? . Journal Watch 2015:7 de mayo. [Ref.ID 99040]
20. Cita con resumen
Anónimo. FDA approves first-of-kind device to treat obesity. FDA U.S. Food and Drug Administration 2015:14 de enero. [Ref.ID 98712]
Seleccionar todas
 
 1 a 20 de 828 siguiente >>